SOLU-CORTEF Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Solu-cortef, and when can generic versions of Solu-cortef launch?
Solu-cortef is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in SOLU-CORTEF is hydrocortisone sodium succinate. There are sixty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the hydrocortisone sodium succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Solu-cortef
A generic version of SOLU-CORTEF was approved as hydrocortisone sodium succinate by CIPLA on September 5th, 2024.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SOLU-CORTEF?
- What are the global sales for SOLU-CORTEF?
- What is Average Wholesale Price for SOLU-CORTEF?
Summary for SOLU-CORTEF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 94 |
| Clinical Trials: | 37 |
| Patent Applications: | 3,242 |
| Drug Prices: | Drug price information for SOLU-CORTEF |
| What excipients (inactive ingredients) are in SOLU-CORTEF? | SOLU-CORTEF excipients list |
| DailyMed Link: | SOLU-CORTEF at DailyMed |
See drug prices for SOLU-CORTEF
Recent Clinical Trials for SOLU-CORTEF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of North Carolina, Chapel Hill | Phase 4 |
| University Medical Center Groningen | Early Phase 1 |
| Beth Israel Deaconess Medical Center | Phase 2 |
Pharmacology for SOLU-CORTEF
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for SOLU-CORTEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | SOLU-CORTEF | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 009866-004 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | SOLU-CORTEF | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 009866-003 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | SOLU-CORTEF | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 009866-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pharmacia And Upjohn | SOLU-CORTEF | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 009866-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
